Anticentromere antibody ? clinical associations
Abstract
The objective of this study was to determine the clinical features of 44 patients with anticentromere antibody (ACA) positivity. We undertook a retrospective review of 44 ACA-positive patients (1 male and 43 females with a mean +/- SD age of 53.6 +/- 12.2 years). There were 25 patients with limited systemic sclerosis, 12 with Raynaud's disease, 2 with Sjögren's syndrome, 2 with systemic lupus erythematosus and 3 with polyarthritis. ACA was more frequently found in patients affected by limited systemic sclerosis with mild visceral involvement and in patients with Raynaud's disease. Moreover, ACA was detected in other connective tissue diseases that were characterized by an atypical autoantibody profile.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Key Biomarkers
Symptom Clusters
Related Papers
- Phytoplankton Toxins and Their Potential Therapeutic Applications: A Journey toward the Quest for Potent PharmaceuticalsMarine Drugs · 2022 · 4 shared tags
- Mechanisms and pharmacotherapy of cancer cachexia‐associated anorexiaPharmacology Research & Perspectives · 2025 · 4 shared tags
- G-Protein-Coupled Receptors in Rheumatoid Arthritis: Recent Insights into Mechanisms and Functional RolesFrontiers in Immunology · 2022 · 4 shared tags
- Inflammation as a link between periodontal disease and obesityPeriodontology 2000 · 2022 · 4 shared tags
- A multi-layered approach to elucidate mechanisms of physical function in response to rehabilitation in heart failure with preserved ejection fractionmedRxiv · 2026 · 4 shared tags
- A Novel Therapeutic Approach to Parkinson's Disease: Using Transcriptomics to Identify Unique Patterns of Gene Expression including 'Triple Positives,' Toll receptors, and Endotoxin ExposureMedical Research Archives · 2025 · 4 shared tags